Substance Use Disorder Readmissions: The Hidden Drain on Star Ratings and Revenue
January 5, 2026
Hospital readmissions are among the most expensive and preventable challenges facing health plans today. While readmissions impact quality across all conditions, substance use disorders stand out as a particularly critical and costly driver of avoidable rehospitalizations with direct consequences for Star Ratings, quality bonus payments, and plan competitiveness.
The financial stakes are substantial. Medicare has withheld over $521 million in a single fiscal year through readmission penalties, and health plans bear the burden of these costs through reduced reimbursements and lost quality bonuses. More critically, Plan All-Cause Readmissions (PCR) is one of the most heavily weighted CMS measures at 3x in the 2025 Star Ratings, making readmission performance a make-or-break factor for quality bonus eligibility.
The SUD-Readmission Crisis: By the Numbers
Substance use disorders are disproportionately represented among readmissions. The data tells a story requiring attention:
- Patients with substance use disorders show a 22.3% readmission rate, significantly higher than the 13.2% rate for mental health conditions
- Research consistently demonstrates that individuals with SUD experience significantly higher readmission rates compared to those without substance use disorders, with one finding showing that in New York, patients with SUD have 24% higher risk of readmission at any point in time and 16% higher risk of 30-day readmission compared to individuals without SUD
- Among Medicaid beneficiaries, readmission rates for individuals with substance use disorders range from 18-26%
These statistics represent real financial exposure for health plans. Substance use disorders cost the country $740 billion annually in costs related to crime, lost work productivity and healthcare, with health plans absorbing a significant portion of these costs through emergency department visits, inpatient stays, and readmissions.
Recent data amplifies the urgency. In 2024, approximately 48.4 million Americans -16.8% of the population aged 12 or older met criteria for a substance use disorder. Yet of the 52.6 million individuals who needed substance use treatment in 2024, only 10.2 million (19.3%) received it. This treatment gap creates a direct pipeline to emergency departments and hospital readmissions.
Why SUD Members Drive Readmissions
SUD members cycle through costly acute care settings due to:
- Emergency Department Overuse: Without proper follow-up care, members return repeatedly for overdose, withdrawal, intoxication, and SUD-related crises. Each ED visit represents both a quality failure and a missed intervention opportunity.
- Cascading Medical Complications: SUD drives infections (endocarditis, hepatitis, HIV), exacerbates chronic diseases, and increases trauma risk—all requiring hospitalization that, without addressing underlying SUD, leads to repeated admissions.
- Co-occurring Mental Health Conditions: Among adults aged 18 or older in 2024, 33.0% (or 86.6 million people) had either any mental illness or a substance use disorder in the past year. Members with both conditions experience worse outcomes and higher readmission rates when care isn’t integrated.
- Care Transition Failures: The 7-30 days following ED discharge, detoxification, or residential treatment represent peak readmission risk. Research confirms that increased follow-up at community mental health centers was associated with lower probabilities of readmission, yet care coordination gaps routinely leave members without support during this critical window.
- Treatment Access Barriers: Common reasons for not receiving treatment include stigma around treatment, cost, lack of knowledge of resources and insufficient health insurance are all barriers that health plans are uniquely positioned to address.
Direct Financial Impact on Health Plans
Poor SUD outcomes create a multi-layered financial burden that extends far beyond the direct costs of hospitalizations.
Star Ratings Revenue at Risk
The connection between readmissions and Star Ratings revenue is direct and substantial. Medicare Advantage plans with four stars or more receive a 5 percent bonus to their benchmark, and in counties with high Medicare Advantage penetration but low traditional Medicare spending, these plans receive a 10 percent bonus.
For perspective: The average annual Quality Bonus Payment per Medicare Advantage enrollee was $352 in 2022, with Medicare Advantage Organizations receiving an estimated $10 billion from CMS in Quality Bonus Program payments that year.
The difference between 3.5 and 4 stars can mean millions in additional federal funding for large plans. With readmissions weighted at 3x in Star Ratings calculations, even modest improvements in SUD readmission rates can generate measurable Star Rating gains.
Medical Cost Management
Each preventable readmission directly impacts the health plan’s medical loss ratio through hospital reimbursements for inpatient stays, emergency department utilization, repeat testing and procedures, intensive case management resources, and medication and treatment costs. These expenses compound quickly when members cycle through acute care without addressing underlying SUD.
For SUD specifically, provision of medication-assisted treatment or residential treatment for substance use disorders after an inpatient or detoxification stay may help prevent future readmissions. The upfront investment in proper treatment and follow-up care yields significant returns through avoided readmissions.
Research demonstrates the financial benefit of intervention. Prescription of anti-craving medications on discharge was associated with decreased 30-day readmission rates, making MAT programs not just clinically sound but financially strategic.
Member Retention and Satisfaction
Poor outcomes damage member satisfaction and CAHPS scores. When members experience repeated crises, hospitalizations, and readmissions without adequate support, they rate their health plan poorly on satisfaction surveys, disenroll during the next enrollment period, share negative experiences that damage plan reputation, and generate higher member acquisition costs as plans struggle to replace lost enrollment. The cascade effect on members’ lifetime value is substantial and measurable.
Employer Group Competitiveness
Large employers increasingly scrutinize quality metrics when selecting health plans for their employees. Plans with poor readmission performance risk losing lucrative employer contracts to competitors with stronger quality profiles and better demonstrated outcomes.
Medicaid Managed Care Implications
For Medicaid managed care plans, the financial implications extend across multiple dimensions. State quality incentive programs tie portions of capitation to readmission performance, creating direct revenue impact. Contract renewal considerations increasingly weigh plan quality metrics, with poor performers facing non-renewal risk. Member auto-assignment algorithms favor higher-performing plans, directing new enrollment away from plans with subpar scores. Public reporting influences member choice in states with voluntary enrollment, making quality performance a competitive differentiator in member acquisition and retention.
How HEDIS SUD Measures Prevent Readmissions
The five HEDIS measures focused on substance use disorders are evidence-based interventions designed to interrupt the readmission cycle at critical points.
Initiation and Engagement of Treatment (IET) ensures members don’t fall through the cracks after diagnosis. By tracking treatment initiation within 14 days and continued engagement through 34 days, this measure identifies gaps before they escalate to crises requiring ED visits and readmissions.
Follow-Up After Emergency Department Visit for SUD (FUA) specifically targets the highest-risk period, which is the 7 and 30 days following an ED visit. Receiving addiction treatment soon after discharge is associated with reduced detoxification readmission, making this measure a direct readmission prevention tool.
Follow-Up After High-Intensity Care for SUD (FUI) addresses the vulnerable transition of discharge from inpatient care, residential treatment, or intensive outpatient programs. Ensuring 7 and 30-day follow-up during this peak-risk period directly prevents readmissions.
Unhealthy Alcohol Use Screening and Follow-Up (ASF-E) focuses on prevention as a proven cost-savings strategy, enabling early identification and brief intervention before alcohol use disorders escalate to crisis levels requiring hospitalization.
Diagnosed Substance Use Disorders (DSU) provides prevalence data to properly resource SUD services and identify screening gaps, ensuring plans have the infrastructure needed to address their member population’s needs.
Strong HEDIS SUD performance correlates directly with lower readmission rates, improved PCR scores, and higher Star Ratings.
Evidence-Based Interventions That Work
Research provides clear guidance on what reduces SUD readmissions:
Medication-Assisted Treatment: Initiation of a discharge-planning protocol, which included treatment with naltrexone, was associated with a decrease in 30-day hospital readmission rates and emergency department visits. Plans should ensure MAT is started during hospitalization and continued post-discharge.
Structured Follow-Up Protocols: The evidence shows prompt outpatient connection prevents readmissions. The key is ensuring these connections actually occur through closed-loop referral systems, not just documenting that referrals were made.
24/7 Engagement and Crisis Support: The gaps between appointments, during treatment waitlists, and in the days immediately following discharge represent the highest-risk periods. Digital tools, peer support, and crisis hotlines that maintain connection during these gaps prevent the deterioration that drives readmissions.
Care Coordination Across Settings: Track members across ED visits, inpatient stays, residential treatment, and outpatient care. Real-time alerts when members access emergency services enable proactive intervention before readmission occurs.
Integrated Physical and Behavioral Health: Given that 33.0% of adults had either any mental illness or a substance use disorder, integrated approaches that address co-occurring conditions simultaneously produce better outcomes than fragmented care.
Why Digital Infrastructure Is Essential
Health plans know what drives SUD readmissions: data blind spots that hide high-risk members until it’s too late, care coordination failures across fragmented networks, claims lag that makes intervention reactive rather than proactive, and the reality that members won’t engage through traditional channels due to stigma. Add 24/7 support needs that exceed any realistic staffing model, and the gap between strategy and execution becomes clear.
Traditional care management models weren’t built to solve these problems, but were designed for scheduled interventions during business hours, not the real-time, always-on demands of preventing SUD readmissions. Digital health infrastructure fundamentally changes what’s possible by:
- Creating closed-loop referral systems with trackable outcomes
- Offering stigma-reducing, app-based tools members can use privately
- Supplementing care management with 24/7 peer support and crisis intervention
- Automating screening and risk stratification to identify members needing intervention before an admission or readmission is imminent
The Strategic Imperative
For health plans, SUD readmission prevention has evolved from a quality initiative to a revenue imperative. With readmissions weighted at 3x in Star Ratings and quality bonuses reaching into the billions, the cost of inaction far exceeds the investment required. The evidence is conclusive that comprehensive SUD infrastructure delivers ROI.
For Medicare Advantage plans, the math is straightforward: Strong SUD performance improves readmission rates, which drives Star Ratings higher, which unlocks quality bonus payments worth hundreds of millions of dollars collectively. Poor SUD performance costs plans directly through lost bonuses and indirectly through higher medical costs and member churn.
For Medicaid managed care plans, the equation is similar: Better SUD outcomes reduce expensive acute care utilization, improve state quality scorecards, enhance contract renewal prospects, and increase member satisfaction.
Plans that build comprehensive SUD care capabilities will capture quality bonus revenue, reduce avoidable costs, and strengthen their competitive position. Success requires decisive action to deploy the infrastructure that transforms SUD performance from a compliance challenge into a strategic differentiator.
